BPA Call HT001419A0035-HT001421F0012

This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Cell Marque Corporation on November 6, 2019 for the delivery of antibodies and kits for the agency's Pathology Department. With a potential value of $78,882.58, the contract has a completion date of November 5, 2020 and does not have a set-aside designation. Cell Marque Corporation will deliver the requested products from their facility located in Bethesda, Maryland to support the...

This federal contract award was made by the Defense Health Agency (DHA) to Cell Marque Corp, a for-profit manufacturer of antibodies and reagents for in vitro diagnostic use. The $74,453.00 firm fixed-price contract, issued as a Blanket Purchase Agreement (BPA) call, is for the delivery of specialized laboratory reagents, antibodies, and diagnostic supplies to support medical facilities including Naval Medical Center San Diego and Walter Reed Medical Center. The contract has an ultimate...

This federal contract award, valued at $55,168.14, was issued by the Defense Health Agency (DHA) to Cell Marque Corporation, a manufacturer and supplier of antibodies and reagents for immunohistochemistry. The award is a firm fixed-price Blanket Purchase Agreement (BPA) call for the delivery of various reagents and peripheral consumables, such as the Marque Corp BOB 1 and CD1a antibody reagents. This BPA contract, with a total potential value of $650,000, serves as an indefinite delivery vehicle...

The Defense Health Agency Contracting Activity awarded a firm fixed-price purchase order contract worth $45,801.00 to Cell Marque Corporation, a manufacturer of antibodies and reagents for in vitro diagnostic use. The contract is for the supply of various Cell Marque antibodies to support immunohistochemical testing using Ventana BenchMark autostainers at the Naval Medical Center San Diego's Laboratory Department. This appears to be a sole source award, as the government determined that Cell...

<p>The Defense Health Agency awarded a blanket purchase agreement call contract to The Binding Site, Inc. for reagents rental services with a potential value of one hundred thousand dollars. The contract has a firm fixed price and requires delivery of the requested reagents to a location in Bethesda, Maryland by April 1, 2020. No set aside provision was applied to this award made under an existing BPA to support the agency's medical research and healthcare programs.</p>

This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Polyscientific Research and Development Corp. to provide reagents and supplies for the agency's Pathology Department. The contract has a potential value of $32,115.85 and requires delivery of the requested products and services by November 10, 2020. Performance will occur in Bethesda, Maryland. No set-aside provision was used for this award to support the Defense Health Agency's...

The Defense Health Agency awarded a $100,000 firm fixed price call order contract to The Binding Site, Inc. of Bethesda, Maryland. The call is against an existing blanket purchase agreement and is for the delivery of reagents and supplies such as diluents, sample cups, and washing solutions to support the Agency's laboratory testing programs. Performance will occur in Bethesda through August 2022. No set-aside provisions were applied to this award to supply critical laboratory consumables and...

<p>The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $500,000 Blanket Purchase Agreement (BPA) Call contract to provide Roche reagents. The contract has a place of performance in Bethesda, Maryland and runs from December 21, 2021 through December 22, 2022 with a Firm Fixed Price pricing structure. Roche Diagnostics Corporation will serve as the prime contractor to supply reagents to the Defense Health Agency, supporting its medical testing needs.</p>

The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $1,534,292.82 firm fixed price blanket purchase agreement (BPA) call contract to provide reagents and supplies. The contract has a period of performance from January 21, 2022 through July 1, 2022 and will be performed in Bethesda, Maryland. Roche Diagnostics Corporation will serve as the prime contractor to supply laboratory reagents and consumable materials to the Defense Health Agency in support of their medical testing...

The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $1,619,613.48 firm fixed price Blanket Purchase Agreement (BPA) Call contract to provide reagents and associated supplies. The contract has a place of performance in Bethesda, Maryland and runs from August 31, 2023 through August 31, 2023. No subcontractors were identified. Roche Diagnostics Corporation will supply laboratory reagents and consumables to support the Defense Health Agency's medical testing requirements.